The pharma company is in the spotlight after BC Investments IV, backed by Bain Capital, initiated a block deal to offload a 2 ...

The Trump administration has warned of high unilateral tariff rates as Japan, South Korea and the EU scrambled to negotiate.

Natco Pharma has taken support near the ₹890 level, which previously acted as a strong base from where the stock had rallied ...

The Indian stock market ended lower on Thursday, weighed down by volatility from the F&O expiry and investor caution ahead of ...

These stocks could be best buys this month according to the broker. The post Bell Potter names more of the best ASX 200 ...

Regulator finds Jane Street manipulated Bank Nifty to profit in options trade and directs disgorgement of ₹4,844 crore while ...

BitMine's explosive rally continued Thursday as investors placed bullish bets on the company's Ethereum treasury stratgey.

Read: Why Circle's proposed national stablecoin trust bank is a smart move ...

It might be gearing up to pay billions of dollars to participate in a drug program currently in development. AstraZeneca ...

The Foreign institutional investors (FIIs) continued the selling on fourth day as they sold equities worth Rs 1481 crore on ...

Shares of Emcure Pharma shall be in focus during the trading session on Friday as Bain Capital-affiliated entity BC ...

Breakout stocks buy or sell: Indian stock market benchmarks, the Sensex and Nifty 50, declined for the second straight session on Thursday, July 3, amid mixed global signals. The Sensex dropped 170 ...